TaiMed Biologics Statistics

Total Valuation

TPEX:4147 has a market cap or net worth of TWD 21.77 billion. The enterprise value is 20.63 billion.

Market Cap	21.77B
Enterprise Value	20.63B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4147 has 273.12 million shares outstanding. The number of shares has increased by 9.00% in one year.

Current Share Class	273.12M
Shares Outstanding	273.12M
Shares Change (YoY)	+9.00%
Shares Change (QoQ)	-1.05%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	6.09%
Float	185.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.40
PB Ratio	5.55
P/TBV Ratio	6.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-84.70
EV / Sales	34.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-49.23

Financial Position

The company has a current ratio of 24.39, with a Debt / Equity ratio of 0.13.

Current Ratio	24.39
Quick Ratio	12.97
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-1.21
Interest Coverage	-22.20

Financial Efficiency

Return on equity (ROE) is -6.00% and return on invested capital (ROIC) is -3.46%.

Return on Equity (ROE)	-6.00%
Return on Assets (ROA)	-3.16%
Return on Invested Capital (ROIC)	-3.46%
Return on Capital Employed (ROCE)	-5.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	0.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.25% in the last 52 weeks. The beta is 0.03, so TPEX:4147's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+0.25%
50-Day Moving Average	86.46
200-Day Moving Average	85.46
Relative Strength Index (RSI)	41.49
Average Volume (20 Days)	700,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4147 had revenue of TWD 598.06 million and -243.51 million in losses. Loss per share was -0.88.

Revenue	598.06M
Gross Profit	243.81M
Operating Income	-253.48M
Pretax Income	-243.51M
Net Income	-243.51M
EBITDA	-106.40M
EBIT	-253.48M
Loss Per Share	-0.88

Full Income Statement

Balance Sheet

The company has 1.65 billion in cash and 507.95 million in debt, giving a net cash position of 1.14 billion or 4.18 per share.

Cash & Cash Equivalents	1.65B
Total Debt	507.95M
Net Cash	1.14B
Net Cash Per Share	4.18
Equity (Book Value)	3.92B
Book Value Per Share	14.51
Working Capital	3.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -406.39 million and capital expenditures -12.58 million, giving a free cash flow of -418.97 million.

Operating Cash Flow	-406.39M
Capital Expenditures	-12.58M
Free Cash Flow	-418.97M
FCF Per Share	-1.53

Full Cash Flow Statement

Margins

Gross margin is 40.77%, with operating and profit margins of -42.38% and -40.72%.

Gross Margin	40.77%
Operating Margin	-42.38%
Pretax Margin	-40.72%
Profit Margin	-40.72%
EBITDA Margin	-17.79%
EBIT Margin	-42.38%
FCF Margin	n/a

Dividends & Yields

TPEX:4147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.00%
Shareholder Yield	n/a
Earnings Yield	-1.12%
FCF Yield	-1.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1